Zhou, X., Yao, Z., Yang, H., Liang, N., Zhang, X., & Zhang, F. (2020). Are immune-related adverse events associated with the efficacy of immune checkpoint inhibitors in patients with cancer? A systematic review and meta-analysis. BMC medicine, 18(1), 87-14. https://doi.org/10.1186/s12916-020-01549-2
Chicago Style (17th ed.) CitationZhou, Xiaoxiang, Zhuoran Yao, Huaxia Yang, Naixin Liang, Xuan Zhang, and Fengchun Zhang. "Are Immune-related Adverse Events Associated with the Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer? A Systematic Review and Meta-analysis." BMC Medicine 18, no. 1 (2020): 87-14. https://doi.org/10.1186/s12916-020-01549-2.
MLA (9th ed.) CitationZhou, Xiaoxiang, et al. "Are Immune-related Adverse Events Associated with the Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer? A Systematic Review and Meta-analysis." BMC Medicine, vol. 18, no. 1, 2020, pp. 87-14, https://doi.org/10.1186/s12916-020-01549-2.